Edwards Lifesciences share price today

Name: Edwards Lifesciences Share Price Today (NASDAQ: EW) - Edwards Lifesciences Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

(EW)

Edwards Lifesciences share price is $69.97 & ₹6,056.95 as on 22 Jan 2025, 2.30 'hrs' IST

$69.97

▲

0.19

(0.27%)

Market is closed - opens 8 PM, 22 Jan 2025

View live Edwards Lifesciences share price in Dollar and Rupees. Guide to invest in Edwards Lifesciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Edwards Lifesciences, along with analyst recommendations, forecasts, and comprehensive financials.

Edwards Lifesciences share price movements

Today's Low: $69.23
Today's High: $70.62
$69.97
1.06%
Downside
Day's Volatility :1.97%
Upside
0.92%
52 Weeks Low: $58.93
52 Weeks High: $96.12
$69.97
15.78%
Downside
52 Weeks Volatility :38.69%
Upside
27.21%

Edwards Lifesciences Returns

Period	Edwards Lifesciences Corp.	Sector (Health Care)	Index (Russel 2000)
3 Months	-1.18%	-7.4%	0.0%
6 Months	-19.75%	-5.2%	0.0%
1 Year	-6.75%	0.5%	0.0%
3 Years	-36.91%	8.3%	-11.0%

Edwards Lifesciences Key Statistics

in dollars & INR

Previous Close	$69.78
Open	$70.2
Today's High	$70.62
Today's Low	$69.23
Market Capitalization	$41.2B
Today's Volume	$4.9M
52 Week High	$96.12
52 Week Low	$58.93
Revenue TTM	$6.3B
EBITDA	$2.1B
Earnings Per Share (EPS)	$2.59
PE Ratio	26.94
Profit Margin	65.86%
Quarterly Earnings Growth YOY	7.16%
Return On Equity TTM	19.14%

How to invest in Edwards Lifesciences from India?

It is very easy for Indian residents to invest directly in Edwards Lifesciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Edwards Lifesciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Edwards Lifesciences or EW on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Edwards Lifesciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Edwards Lifesciences shares which would translate to 0.012 fractional shares of Edwards Lifesciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Edwards Lifesciences, in just a few clicks!

Returns in Edwards Lifesciences for Indian investors in Rupees

Investment Value

₹1,00,000

Edwards Lifesciences investment value today

Current value as on today

₹97,657

Returns

₹2,343

(-2.34%)

Returns from Edwards Lifesciences Stock

₹6,495 (-6.49%)

Dollar Returns

₹4,152 (+4.15%)

Indian investors sentiment towards Edwards Lifesciences

-48%

Period: Oct 23, 2024 to Jan 21, 2025. Change in 30 Days versus previous period

Search volume for Edwards Lifesciences on INDmoney from India has reduced in the last 30 days as on Jan 22, 2025. -48% less investors are searching Edwards Lifesciences in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Edwards Lifesciences

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	5088	0.10	0.09%

Global Institutional Holdings in Edwards Lifesciences

Vanguard Group Inc
10.61%
BlackRock Inc
9.25%
Wellington Management Company LLP
5.35%
State Street Corp
4.45%
Bank of New York Mellon Corp
3.10%
Geode Capital Management, LLC
2.29%

Analyst Recommendation on Edwards Lifesciences

Buy

60%Buy

35%Hold

5%Sell

Based on 40 Wall street analysts offering stock ratings for Edwards Lifesciences(by analysts ranked 0 to 5 stars)

Based on 40 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Edwards Lifesciences

What analysts predicted

Upside of 12.79%

Target:

$78.92

Current:

$69.97

Insights on Edwards Lifesciences

Price Movement
In the last 7 days, EW stock has moved down by -1.8%
Decreasing Revenue
Edwards Lifesciences Corp. has experienced a decline in revenue for the last three quarters. Revenue decreased from $1.59 billion to $1.35 billion, reflecting an average decrease of 7.8% per quarter.
Increasing Net Profit
Edwards Lifesciences Corp. has shown strong profit growth over the last three quarters. Their net profit increased from $351.9 million to $3.07 billion, which is an average rise of 46.0% each quarter.
EW vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 61.9% return, outperforming this stock by 68.0%
EW vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 129.6% return, outperforming this stock by 167.7%
Price to Sales
Investors are currently willing to pay $6.6 for every $1 of sales generated by Edwards Lifesciences Corp. In comparison, investors are paying $9.1 for every $1 of sales from Boston Scientific Corp. This indicates that Edwards Lifesciences has a lower price-to-sales ratio than Boston Scientific, suggesting that investors may perceive it as relatively undervalued based on its sales.

Edwards Lifesciences Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$3.7B	↑ 8.37%
Net Income	$722.2M	↑ 16.09%
Net Profit Margin	19.4%	↑ 1.29%

	FY19	Y/Y Change
Revenue	$4.3B	↑ 16.79%
Net Income	$1.0B	↑ 44.96%
Net Profit Margin	24.08%	↑ 4.68%

	FY20	Y/Y Change
Revenue	$4.4B	↑ 0.88%
Net Income	$823.4M	↓ 21.35%
Net Profit Margin	18.77%	↓ 5.31%

	FY21	Y/Y Change
Revenue	$5.2B	↑ 19.29%
Net Income	$1.5B	↑ 82.55%
Net Profit Margin	28.73%	↑ 9.96%

	FY22	Y/Y Change
Revenue	$5.4B	↑ 2.86%
Net Income	$1.5B	↑ 1.25%
Net Profit Margin	28.28%	↓ 0.45%

	FY23	Y/Y Change
Revenue	$6.0B	↑ 11.56%
Net Income	$1.4B	↓ 7.85%
Net Profit Margin	23.35%	↓ 4.93%

	Q2 FY23	Q/Q Change
Revenue	$1.5B	↑ 4.84%
Net Income	$307.1M	↓ 9.81%
Net Profit Margin	20.07%	↓ 3.26%

	Q3 FY23	Q/Q Change
Revenue	$1.5B	↓ 3.22%
Net Income	$384.9M	↑ 25.33%
Net Profit Margin	25.99%	↑ 5.92%

	Q4 FY23	Q/Q Change
Revenue	$1.5B	↑ 3.59%
Net Income	$369.9M	↓ 3.9%
Net Profit Margin	24.11%	↓ 1.88%

	Q1 FY24	Q/Q Change
Revenue	$1.6B	↑ 4.18%
Net Income	$351.9M	↓ 4.87%
Net Profit Margin	22.02%	↓ 2.09%

	Q2 FY24	Q/Q Change
Revenue	$1.4B	↓ 13.28%
Net Income	$366.3M	↑ 4.09%
Net Profit Margin	26.43%	↑ 4.41%

	Q3 FY24	Q/Q Change
Revenue	$1.4B	↓ 2.27%
Net Income	$3.1B	↑ 738.33%
Net Profit Margin	226.73%	↑ 200.3%

	FY18	Y/Y Change
Profit	$2.8B	↑ 8.73%

	FY19	Y/Y Change
Profit	$3.2B	↑ 16.17%

	FY20	Y/Y Change
Profit	$3.3B	↑ 2.23%

	FY21	Y/Y Change
Profit	$4.0B	↑ 20.51%

	FY22	Y/Y Change
Profit	$4.3B	↑ 7.99%

	FY23	Y/Y Change
Profit	$4.6B	↑ 7.51%

	Q2 FY23	Q/Q Change
Profit	$1.2B	↑ 5.05%

	Q3 FY23	Q/Q Change
Profit	$1.1B	↓ 4.78%

	Q4 FY23	Q/Q Change
Profit	$1.2B	↑ 4.13%

	Q1 FY24	Q/Q Change
Profit	$1.2B	↑ 3.13%

	Q2 FY24	Q/Q Change
Profit	$1.1B	↓ 10.37%

	Q3 FY24	Q/Q Change
Profit	$1.1B	↑ 0.31%

	FY18	Y/Y Change
Operating Cash Flow	$926.8M	↓ 7.38%
Investing Cash Flow	$76.7M	↓ 111.85%
Financing Cash Flow	$-1.1B	↑ 132.71%

	FY19	Y/Y Change
Operating Cash Flow	$1.2B	↑ 27.26%
Investing Cash Flow	$-595.8M	↓ 876.79%
Financing Cash Flow	$-115.6M	↓ 89.5%

	FY20	Y/Y Change
Operating Cash Flow	$1.1B	↓ 10.61%
Investing Cash Flow	$-531.1M	↓ 10.86%
Financing Cash Flow	$-486.9M	↑ 321.19%

	FY21	Y/Y Change
Operating Cash Flow	$1.7B	↑ 64.29%
Investing Cash Flow	$-1.7B	↑ 224.33%
Financing Cash Flow	$-356.3M	↓ 26.82%

	FY22	Y/Y Change
Operating Cash Flow	$1.2B	↓ 29.67%
Investing Cash Flow	$252.3M	↓ 114.65%
Financing Cash Flow	$-1.6B	↑ 344.71%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$33.6M	↓ 89.3%
Investing Cash Flow	$70.2M	↑ 13940.0%
Financing Cash Flow	$52.1M	↓ 125.22%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$411.5M	↑ 1124.7%
Investing Cash Flow	$159.7M	↑ 127.49%
Financing Cash Flow	$-143.3M	↓ 375.05%

Edwards Lifesciences Technicals Summary

Sell

Neutral

Buy

Edwards Lifesciences is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Edwards Lifesciences Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Edwards Lifesciences Corp.	-6.72%	-19.75%	-6.75%	-36.91%	-9.16%
Medtronic Plc	8.21%	10.14%	2.02%	-15.48%	-26.14%
Boston Scientific Corp.	9.79%	26.88%	62.75%	131.27%	128.33%
Stryker Corporation	4.62%	12.63%	22.82%	52.2%	78.98%
Abbott Laboratories	-0.73%	5.8%	-0.46%	-8.35%	25.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Edwards Lifesciences Corp.	26.94	26.94	6.41	2.55	0.19	0.11	NA	16.18
Medtronic Plc	26.94	26.94	1.5	5.45	0.08	0.04	0.03	38.29
Boston Scientific Corp.	81.54	81.54	1.79	2.46	0.09	0.05	NA	14.05
Stryker Corporation	41.14	41.14	2.68	12.06	0.19	0.07	0.01	52.86
Abbott Laboratories	34.49	34.49	2.2	4.67	0.15	0.06	0.02	22.94

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Edwards Lifesciences Corp.	Buy	$41.2B	-9.16%	26.94	65.86%
Medtronic Plc	Buy	$112.9B	-26.14%	26.94	12.06%
Boston Scientific Corp.	Buy	$145.4B	128.33%	81.54	11.26%
Stryker Corporation	Buy	$146.2B	78.98%	41.14	16.34%
Abbott Laboratories	Buy	$196.8B	25.53%	34.49	13.99%

About Edwards Lifesciences

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Organization	Edwards Lifesciences
Employees	19800
CEO	Mr. Bernard J. Zovighian
Industry	Health Technology

Management People of Edwards Lifesciences

Name	Title
Mr. Bernard J. Zovighian	CEO & Director
Mr. Scott B. Ullem	Corporate VP & CFO
Mr. Donald E. Bobo Jr.	Corporate Vice President of Strategy & Corporate Development
Mr. Larry L. Wood	Corporate VP and Group President of TAVR & Surgical Structural Heart
Mr. Andrew M. Dahl	Principal Accounting Officer, Senior VP & Corporate Controller
Dr. Todd J. Brinton FACC, M.D.	Corporate VP of Advanced Technology & Chief Scientific Officer
Mr. Mark Wilterding	Vice President of Investor Relations
Mr. Arnold A. Pinkston J.D.	Corporate VP & General Counsel
Mr. Dirksen J. Lehman	Corporate Vice President of Public Affairs
Ms. Christine Z. McCauley	Corporate Vice President of Human Resources

Important FAQs about investing in Edwards Lifesciences from India :

What is Edwards Lifesciences share price today?

Edwards Lifesciences share price today stands at $69.97, Open: $70.20 ; Previous Close: $69.78 ; High: $70.62 ; Low: $69.23 ; 52 Week High: $96.12 ; 52 Week Low: $58.93. The stock opens at $70.20, after a previous close of $69.78. The stock reached a daily high of $70.62 and a low of $69.23, with a 52-week high of $96.12 and a 52-week low of $58.93.

Can Indians buy Edwards Lifesciences shares?

Yes, Indians can invest in the Edwards Lifesciences (EW) from India.

With INDmoney, you can buy Edwards Lifesciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Edwards Lifesciences at zero transaction cost.

How can I buy Edwards Lifesciences shares from India?

It is very easy to buy Edwards Lifesciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Edwards Lifesciences be purchased?

Yes, you can buy fractional shares of Edwards Lifesciences with INDmoney app.

What are the documents required to start investing in Edwards Lifesciences stocks?

To start investing in Edwards Lifesciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.